Abstract
As significantly expressed during cell division, polo-like kinase 1 (PLK1) plays crucial roles in numerous mitotic events and has attracted interest as a potential therapeutic marker in oncological drug discovery. We prepared two small molecular fluorescent probes, 1 and 2, conjugated to SBE13 (a type II PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer cells and tumors. Enzymatic docking studies, molecular dynamics simulations, and in vitro and in vivo imaging experiments all supported the selective targeting and visualization of PLK1 expressing cells by probes 1 and 2, and probe 2 was successfully demonstrated to image PLK1-upregulated tumors with remarkable signal-to-background ratios. These findings represent the first example of small-molecule based fluorescent imaging of tumors using PLK1 as a target, which could provide new avenues for tumor diagnosis and precision therapeutics.
Original language | English |
---|---|
Pages (from-to) | 1512-1516 |
Number of pages | 5 |
Journal | ACS Sensors |
Volume | 2 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2017 Oct 27 |
Bibliographical note
Funding Information:This work was supported by the Ministry of Science, ICT & Future Planning (MSIP) of Korea (No. 2009-0081566 for J.S.K.) National Research Foundation of Korea (NRF-20158A2A1A01005389 for S.G.C.).
Keywords
- PLK1
- SBE13
- fluorescence
- high SBR ratio
- targeted imaging
ASJC Scopus subject areas
- Bioengineering
- Instrumentation
- Process Chemistry and Technology
- Fluid Flow and Transfer Processes